These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 18480888)

  • 1. Drug-eluting stent implantation for radial artery graft aorta-ostial stenosis.
    McKay E; Ramsdale KA; Ramsdale DR
    N Z Med J; 2008 May; 121(1273):66-8. PubMed ID: 18480888
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of radial artery patency according to proximal anastomosis site: direct aorta to radial artery anastomosis is superior to radial artery composite grafting.
    Jung SH; Song H; Choo SJ; Je HG; Chung CH; Kang JW; Lee JW
    J Thorac Cardiovasc Surg; 2009 Jul; 138(1):76-83. PubMed ID: 19577060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technical difficulty in stenting Supralimus in radial artery graft.
    Meireles GC; Kreimer S; Galon MZ; Marchiori GG
    Arq Bras Cardiol; 2011 Apr; 96(4):e69-72. PubMed ID: 21552650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of ostial lesions using the Szabo technique: a case series.
    Applegate RJ; Davis JM; Leonard JC
    Catheter Cardiovasc Interv; 2008 Nov; 72(6):823-8. PubMed ID: 18798240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anchoring the stent: comment on treatment of ostial lesions using the Szabo technique. A case series by Applegate R et al.
    Kern MJ
    Catheter Cardiovasc Interv; 2008 Nov; 72(6):829-30. PubMed ID: 19009628
    [No Abstract]   [Full Text] [Related]  

  • 6. Stent implantation in saphenous vein grafts.
    Lozano I; Avanzas P; Rondan J
    Am J Cardiol; 2009 Apr; 103(7):1042-3. PubMed ID: 19327440
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of drug-eluting stents in venous coronary artery bypass grafts.
    Hernandez-Antolín R; Alfonso F; Jimenez P
    EuroIntervention; 2009 May; 5 Suppl D():D51-7. PubMed ID: 19736072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents 70 restenotic cases from a cohort of 718 patients: FAILS (Failure in Left Main Study).
    Sheiban I; Sillano D; Biondi-Zoccai G; Chieffo A; Colombo A; Vecchio S; Margheri M; Gunn JP; Raina T; Liistro F; Bolognese L; Lee MS; Tobis J; Moretti C
    J Am Coll Cardiol; 2009 Sep; 54(13):1131-6. PubMed ID: 19761932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late stenosis of aorto-aortic bypass graft treated by self-expandable stent implantation.
    Peregrin JH; Frídl P; Tintĕra J
    Cardiovasc Intervent Radiol; 2004; 27(4):386-8. PubMed ID: 15129330
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug-eluting stent treatment of a radiation-induced left internal mammary arterial graft stenosis.
    Puri R; Dundon BK; Worthley MI; Worthley SG; Brown MA
    Circ J; 2008 Nov; 72(11):1904-6. PubMed ID: 18787292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent late drug-eluting stent thrombosis upon discontinuation of antiplatelet therapy.
    Varghese I; Ummer A; Roesle M; Banerjee S; Brilakis ES
    Cardiovasc Revasc Med; 2008; 9(3):179-81. PubMed ID: 18606381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous revascularization in patients with previous coronary artery bypass graft surgery. Immediate and 1-year clinical outcomes.
    Tejada JG; Velazquez M; Hernandez F; Albarran A; Gomez I; Rodriguez S; Andreu J; Tascon J
    Int J Cardiol; 2009 May; 134(2):201-6. PubMed ID: 18508141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endovascular management of symptomatic spasm of radial artery bypass graft: technical case report.
    Natarajan SK; Hauck EF; Hopkins LN; Levy EI; Siddiqui AH
    Neurosurgery; 2010 Sep; 67(3):794-8; discussion 798. PubMed ID: 20657319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major adverse cardiac events at follow-up after bare-metal stenting versus drug-eluting stenting in ST-elevated myocardial infarction.
    Pierre-Louis B; Aronow WS; Palaniswamy C; Singh T; Ahn C; Asija A; Weiss MB; Kalapatapu K; Pucillo AL; Monsen CE
    Am J Cardiol; 2009 Jun; 103(12):1672-4. PubMed ID: 19539074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of clinical long-term benefit with the use of a drug eluting stent compared to use of a bare metal stent in saphenous vein grafts.
    Gioia G; Benassi A; Mohendra R; Chowdhury K; Masood I; Matthai W
    Catheter Cardiovasc Interv; 2008 Jul; 72(1):13-20. PubMed ID: 18561143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of drug-eluting stent restenosis with another drug-eluting stent: do not fail the second time!].
    Colombo A; Latib A
    Rev Esp Cardiol; 2008 Nov; 61(11):1120-2. PubMed ID: 19000485
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug-eluting stent in saphenous vein graft lesions.
    Kornowski R
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):894-5. PubMed ID: 18498140
    [No Abstract]   [Full Text] [Related]  

  • 18. Radial artery as the second choice conduit: some unsolved problems.
    Raja SG
    Circulation; 2004 Aug; 110(6):e62-3; author reply e62-3. PubMed ID: 15302810
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term benefit-risk balance of drug-eluting vs. bare-metal stents in daily practice: does stent diameter matter? Three-year follow-up of BASKET.
    Pfisterer M; Brunner-La Rocca HP; Rickenbacher P; Hunziker P; Mueller C; Nietlispach F; Leibundgut G; Bader F; Kaiser C;
    Eur Heart J; 2009 Jan; 30(1):16-24. PubMed ID: 19033260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xience V everolimus-eluting coronary stent.
    Kukreja N; Onuma Y; Serruys PW
    Expert Rev Med Devices; 2009 May; 6(3):219-29. PubMed ID: 19419279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.